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Each year in the United States, 486,000 people 
receive medical treatment for burn injuries and 
40,000 of these are hospitalized, including 30,000 
who are hospitalized at burn centers.1 Efforts to 
improve outcomes from burn injuries rely on a bet-
ter understanding of the factors related to the injury 
including the pathophysiology, barriers to treatment, 
and factors that increase morbidity and mortal-
ity. Enrollment of burn patients is usually straight-
forward in the case of observational studies and 
repositories for which informed consent may not be 
required.2 However, less is known about issues sur-
rounding enrollment of these patients in prospective 
studies with informed consent. Prospective studies 
improve data quality compared to retrospectively 
collected data, and improving enrollment into pro-
spective studies allows data to be obtained more effi-
ciently, thereby increasing the generalizability of the 
data collected.
Several studies have been published in the past 
decade regarding the recruitment of critically ill 
patients,3 patient preferences for enrollment in 
critical-care trials,4 and the attitudes of surrogate 
decision makers’ (SDM) towards research decision 
making for critically ill patients.5 However, burn 
injured patients have long been acknowledged to be 
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a unique population. For example, severely burned 
patients were excluded from the early Acute Respira-
tory Distress Syndrome Network studies.6 Dr. Saffle, 
a well-recognized surgeon, has also described the 
social and medical challenges involved in the care of 
burn patients that are different from other patients.7 
Therefore, findings from other populations of criti-
cally ill patients may not be applicable to burn injured 
patients.
In this article, we compared time to enrollment 
before and after iterative changes to the process of 
recruiting severely burned patients into two nonin-
terventional studies at a busy academic burn center 
(>1500 burn unit admissions annually). We incorpo-
rate our findings into a brief literature review of the 
barriers, motivators, and roles of SDMs and physi-




Our institution is an 850-bed academic tertiary care 
facility including a 21-bed intensive care unit (ICU) 
for severely injured adult and pediatric patients with 
burns or extensive exfoliating skin conditions. In 
November 2015, we began enrolling patients into 
two noninterventional studies: 1) an observational 
study of infections occurring during burn ICU 
admission with analysis of Gram-negative bacterial 
isolates obtained from clinical patient specimens 
and 2) a minimally invasive study with collection of 
weekly surveillance wound and perirectal cultures 
using sterile swabs and twice weekly aseptically col-
lected tracheal aspirate cultures of intubated patients 
to isolate Gram-negative bacteria from these samples. 
The goal of these studies was to identify changes in 
the microbial milieu of patients admitted to the burn 
unit during their hospital stay. We included patients 
who met the following criteria 1) age ≥18 years, 2) 
percentage TBSA burn ≥20 or inhalation injury, 3) 
fluency in either English or Spanish, 4) presentation 
within 2 days of injury, and 5) anticipated length of 
stay in the burn ICU of at least 5 days.
Consent and Recruitment
Both studies were approved by our institutional 
review board and operated with informed consent. 
Initial consent from an SDM was acceptable for 
patients unable to provide consent. Nonconsented 
patients were given the opportunity to withdraw 
study consent provided by an SDM when they were 
no longer incapacitated or impaired.
The principal investigator (PI), a regular con-
sulting physician in the burn unit but not a burn 
surgeon, was involved in the recruitment process 
for some patients. Formal informed consent was 
obtained by a trained research coordinator. Multiple 
strategies were instituted prior to study commence-
ment to maximize recruitment. These strategies are 
listed in Table 1 and included, for example, the avail-
ability of both English and Spanish consent forms.
Iterative Changes in the Recruitment Process
Throughout the initial 4 months of the study 
(November 9, 2015, to February 29, 2016), we per-
ceived several weaknesses in our recruitment process 
leading to delays in enrollment. As a result, several 





1. Consents forms in English
and Spanish
1. Deliberate delay of approach
of SDM and patients until
approximately 48 hours after
admission and until pain
controlled
2. Phone scripts and IRB
approval to obtain verbal
consent from SDMs by
phone
2. Physician PI outreach if
no response obtained
from SDM after 48 hours
of approach by research
coordinator
3. IRB approval to obtain
verbal consent for patients
unable to sign forms due
to burn injuries
3. Request participation in the
observational study prior to
discussing the study with
minimally invasive sample
collection
4. Option for observational
participation only or
option to participate with
only some invasive samples
4. Mail or email consent forms
to SDM after obtaining
verbal phone consent with
phone script
5. IRB approval to obtain
admission samples on




the physician PI and
the consenting research
coordinator
6. Involvement of caseworker






8. No strictly defined time
window for enrollment
IRB, institutional review board; PI, principle investigator; SDM, surrogate 
decision maker.
iterative modifications were made to our recruitment 
process during months 4 to 6 of the study to try to 
improve this process (Table 1). First, patients 
and SDMs appeared to decline a discussion of 
research on admission because of pain or feeling 
overwhelmed. Therefore, we delayed the approach 
of SDMs until 48 hours after admission and 
delayed approaching patients by at least 24 to 48 
hours and until pain was adequately controlled. 
We began to recruit patients to the study that 
did not require invasive sample collection first; if 
this study was deemed to be potentially acceptable, 
we then proceeded to broach the second study 
involving patient specimen collec-tion. Before 
study initiation, the institutional review board 
approved a waiver of written consent for 
physically injured patients and permission to obtain 
verbal consent from SDMs with phone scripts. How-
ever, in the early study period, we often had delays 
waiting for the SDM to receive and read physical 
copies of study forms sent by mail or email before 
attempting to obtain consent. So in later months, 
we mailed consent forms after consent was obtained 
by phone and offered the SDM the opportunity to 
withdraw consent if the SDM felt that paper docu-
ments were incongruent with the phone script. As 
some patients and SDMs appeared to respond better 
to approach by the PI, the PI became increasingly 
involved in the recruitment process throughout the 
later months. Finally, the PI and research coordi-
nator also standardized the processes of screening, 
approaching patients, and communicating with each 
other to limit duplicate work and delays. We used 
the second 4 months of the study (March 1, 2016, 
to June 24, 2016) to represent time after our inter-
ventional modifications.
Data Analysis
Results are displayed as median and interquartile 
range (IQR) for continuous variables and numbers 
and percentages for categorical variables. Bivariate 
analyses were performed to examine the associa-
tions between patient characteristics and enrollment 
as well as the associations between enrollment and 
time to enrollment in the first 4 months (before 
intervention) and second 4 months of the study 
(after intervention). As several continuous variables 
were non-normal and the sample size was small, the 
Wilcoxon’s rank-sum test was used for continuous 
variables and the Fisher’s exact test was used for cat-
egorical variables. All P values were two sided, and 
P < .05 was considered statistically significant. Stata 
statistical software (release 13; StataCorp LP, Col-
lege Station, TX) was used for all analyses.
The two extracorporeal membrane oxygenation 
(ECMO) patients transferred units before an SDM 
could be approached and were considered nonen-
rolled as of the day of transfer as they were no longer 
eligible for recruitment at that time. One ECMO 
patient was eligible for the observational study alone 
after returning to burn unit following ECMO: he 
was consented by SDM but later withdrew consent. 
To be conservative, he remained as nonenrolled as of 
the day of transfer in our analyses.
RESULTS
Over an 8-month period from November 9, 2015, 
to June 24, 2016, 296 admissions to our burn ICU 
were screened for eligibility (Figure 1). Forty patients 
met inclusion criteria. Of eligible patients, 27 (68%) 
were male, 28 (70%) were white, and 40 (100%) 
spoke English as their preferred language. Twenty-
eight patients (70% of those eligible) were enrolled, 
3 (7.5%) patients declined, 3 (7.5%) SDMs declined, 
4 (10%) died prior to recruitment, and 2 (5%) were 
transferred out of the burn ICU for ECMO during 
recruitment. Of eligible patients, 34 (85%) patients 
required initial recruitment via an SDM, and 6 (15%) 
patients were recruited directly. Four patients (10%) 
began the recruitment process requiring an SDM 
but regained the ability to consent for themselves 
before the SDM could be identified or before the 
SDM made a decision regarding study participation. 
One patient withdrew consent after it was provided 
by an SDM. One patient directly consented to the 
observational study alone, but all other patients or 
SDMs consented to or declined both studies.
Characteristics of all patients who were and were 
not enrolled in either study during the entire study 
period are shown in Table 2. Compared to those 
patients who were not enrolled, enrolled patients 
were more often male (71% vs 58%), more often 
white (79% vs 50%), and more often had inhalation 
injury (50% vs 33%). However, none of these char-
acteristics reached statistical significance in our small 
study population.
Study enrollment prior to the intervention was 
68% and 73% (P = 1.0) in the later time period after 
the intervention (Table 3). Following the interven-
tion, time to consent by an SDM decreased from a 
median of 26.5 days (IQR 14–41) to 3 days (IQR 
3–6). Time to initial consent by patients changed 
from a median of 15 days (IQR 2–30) to 3 days 
(IQR 2–6). Time to decline of nonenrolled patients 
decreased from a median of 12 days (IQR 6.5–27) 
to 1.5 days (IQR 1–3.5). Both the change in time to 
consent by SDM and the change time to cessation 
of recruitment were statistically significant (P < .05).
DISCUSSION
An insufficient amount of literature exists to advise 
investigators on how to conduct clinical trials in 
burn patients, specifically addressing the barriers to 
research participation and how to overcome those 
barriers to improve recruitment into burn stud-
ies. Despite a study design that anticipated several 
barriers in the prestudy protocol design phase, we 
struggled to enroll patients in a timely and efficient 
manner. We made several changes to our recruit-
ment process that decreased the time to patient 
enrollment or decline. Although the downstream 
consequences of our recruitment changes were not 
measured, our interventions likely decreased wasted 
effort by research coordinators on missed SDM and 
patient encounters, decreased delays to patient chart 
abstraction, and improved time to collection of the 
second surveillance specimen.
Compared to other critically ill populations, 
several advantages exist that would seem to favor 
recruitment of severely injured burn patients into 
research. Although types of burn injury certainly 
effect prognosis, the target population is fairly easily 
defined by the trauma of burn injury. The aggrega-
tion of 60% of burn admissions at 128 U.S. burn cen-
ters should improve ability to access this population 
for research.1 Severely injured burn patients often 
require multiple surgeries or long inpatient stays that 
make them a captive audience for recruitment. In 
addition, burn centers provide very specialized treat-
ment paradigms by consistent faculty standardizing 
care for the patient population seen in that center.
However, barriers to research participation may 
exist in the burn population that are not present in 
other critically ill populations. The shocking nature of 
burn trauma and the associated consequences beyond 
Figure 1. Study flow diagram. ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; SDM, surrogate 
decision maker.
injury, like unstable housing, may make encounters 
about research unbearably overwhelming. Extreme 
pain may limit a burn patient’s ability to focus on a 
discussion of research risks and benefits. Although we 
did not examine causality, we observed that SDMs 
and patients were more willing to hear about research 
if we waited to approach them approximately 48 
hours after admission and when pain was adequately 
controlled. Mental health diagnoses, education and 
income level, and motivation for enrollment were not 
collected in the pre-enrollment period of our study, 
but these factors are also likely to be important in 
fully understanding barriers to participation in burn 
research and the ability to consent.
Table 2. Characteristics of all patients eligible for study enrollment
Eligible Patients Enrolled in Either 
Study, n = 28 (70%)
Eligible Patients Not Enrolled,  
n = 12 (30%) P*
Age at admission, years, median, IQR 51.5 (36–63) 56.5 (40–69) .36
Sex
Male 20 (71) 7 (58) .48
Female 8 (29) 5 (42)
Race
White 22 (79) 6 (50) .07
Black 6 (21) 4 (33)
Other/unknown 0 (0) 2 (16)
Preferred language
English 28 (100) 12 (100) NA
Spanish 0 (0) 0 (0)
Total body surface area, Percentage, median, IQR
Percentage, median, IQR
18.0 (1–37.5) 16.5 (0–25) .32
Inhalation injury
Yes 14 (50) 4 (33) .49
No 14 (50) 8 (67)
Decision maker
Surrogate 21 (75) 3 (25) .33†
Patient 7 (25) 3 (25)
Not applicable (died/transferred prior to recruitment) 0 (0) 6 (50)
Study enrollment includes all patients before and after the intervention. Data are given as number (percentage) unless otherwise indicated.
*P values were calculated with the Wilcoxon’s rank-sum test for continuous variables and the Fisher’s exact test for categorical variables.
†Patients who died/transferred prior to recruitment were excluded when calculating the P value for decision maker.
IQR, interquartile range; NA, not applicable.
Table 3. Differences in enrollment before and after the intervention
Before Intervention  
Nov 9, 2015, to Feb 29, 2016 
(112 days)
After Intervention  
Mar 1, 2016, to June 24, 2016  
(115 days) P*
Screened patients, N 139 157
Eligible patients, n (% of patients screened) 25 (18) 15 (10)
Enrollment
1.0Enrolled patients, n (% of patients eligible) 17 (68) 11 (73)
Initial consent by SDM, n (% enrolled) 14 (82) 7 (64)
Initial consent by self, n (% enrolled) 3 (18) 4 (36)
 Nonenrolled patients†, n (% of patients eligible) 8 (32) 4 (27)
Days to initial consent or decline
Days to initial consent by SDM, median, IQR 26.5 (14–41) 3 (3–6) .004
Days to initial consent by self, median, IQR 15 (2–30) 3 (2–6) .27
Days to decline for nonenrolled patients, median, IQR 12 (6.5–27) 1.5 (1–3.5) .026
*P values were calculated with the Wilcoxon’s rank-sum test for continuous variables and the Fisher’s exact test for categorical variables.
†Patient/SDM declined or patient died/transferred during recruitment.
IQR, interquartile range; SDM, surrogate decision maker.
SDMs play a crucial role in studies of critically ill 
patients. Eighty-seven percent of patients surveyed 
after critical illness describe research consent pro-
vided by an SDM as acceptable or highly acceptable.4 
SDM rationale for providing or declining consent in 
the ICU has been previously described.8 Frequent 
reasons that SDMs provide consent include 1) belief 
that the patient will benefit from participation, 2) a 
strong desire to help others, 3) wanting to advance 
medical knowledge, and 4) the belief that their loved 
one would want to participate. The most common 
SDM reasons for declining consent were 1) 
uncer-tainty about their loved one’s wishes 
regarding research participation and 2) the concern 
that the risk may be greater than the benefits for 
their loved one.
In our experience, we found that SDM often 
expressed a “need to discuss it [research] with other 
family members.” We were surprised that this seemed 
to apply to both the noninvasive study and the study 
with minimally invasive specimen collection. From 
our perspective, SDMs seemed to want to discuss with 
additional family members the more general concept 
of whether the patient would be willing to participate 
in any type of research rather than the specific patient 
data or samples that would be collected throughout 
the studies. Of the SDMs that gave consent, none of 
them consented to the observational study alone. If 
the SDMs provided consent, they consented to both 
the observational and minimally invasive studies. This 
suggests that the reason for declining consent did not 
stem from fear surrounding the discomfort or distress 
due to surveillance specimen collection but rather 
due to other reasons.
Physicians also likely play an important role in the 
decision to participate in burn research. Physicians 
have been described as both a barrier to study enroll-
ment for failing to refer eligible patients to clinical tri-
als and a motivator for participation in trials because 
patients trust their doctor’s recommendation.9 A 
study of physician vs nonphysician approach of SDMs 
in the ICU for consent found that 87.5% of SDMs 
felt that physician involvement was inconsequential.8 
Instead, SDMs prioritized the personal attributes of 
the person approaching them over professional desig-
nation. Another study found that 85% of SDMs indi-
cated that a medical update from an ICU physician 
prior to a discussion about research would be helpful 
and 53% wanted the treating intensivist involved in 
the research decision-making process.5 When design-
ing our study, we chose not to involve the burn sur-
gery ICU attending in recruitment given concern 
that their involvement could be considered coercive. 
However, these findings of Barrett et al suggest that 
SDMs may not perceive ICU attending involvement 
in recruitment as such.
As our study progressed, the physician PI became 
increasingly involved in recruitment although no 
patients were officially consented by the PI. In our 
experience, SDMs and patients seemed more likely to 
return phone calls and to be willing to listen about 
research introduced by a physician than a research 
coordinator. Introduction of the research topic by the 
investigating physician could influence decision mak-
ing in several possible ways: 1) by making the research 
topic appear more important or more interesting, 2) 
by making research participation sound more appeal-
ing, or 3) by creating a feeling of desire to express 
gratitude to the care team. Some or all of these factors 
may have contributed the decreased time to enroll-
ment noted in the late period of our study.
Finally, the Canadian Clinical Care Trials Group 
recently published the results of The Consent Study 
in 2013 describing challenges of implementing acute 
care research.3 The most notable conclusions from 
this study were that 1) a large gap existed between 
eligibility and the frequency of consent encounters in 
the ICU and 2) recruitment was highly susceptible 
to design and procedural inefficiencies and to per-
sonnel availability. These findings are very consistent 
with what we experienced our study. The patients 
who died prior to recruitment in the early period 
our study were likely due to missed or infeasible 
opportunities for recruitment or to the challenges 
of approaching SDMs of critically injured patients 
about research by phone and the limited availability 
of staff to meet with them in person.
As this is an observational study, we cannot con-
clude with certainty that all differences in time to 
enrollment were directly related to the interventional 
modifications. However, given that the process mod-
ifications were directed toward perceived weaknesses, 
the intervention likely did have an important effect. 
Three additional factors varied between the study 
periods that limit our ability to attribute the full effect 
to our intervention alone. First, fewer eligible patients 
were admitted to the burn ICU during the later 
study period, which may have led to fewer demands 
on the recruitment team during this time. This expla-
nation is unlikely to be sufficient to explain all of our 
findings because multiple research coordinator par-
ticipated in the earlier recruitment period whereas a 
single research coordinator recruited patients in the 
later period. Second, a larger proportion of patients 
in the second period were able to consent for them-
selves, which may have made them more easily acces-
sible to the recruitment team. However, because 
SDMs could be recruited by telephone, SDMs may 
have been as accessible for recruitment as hospital-
ized patients who could be occupied by procedures 
or therapy or be unwilling to discuss research due to 
pain. Lastly, the increased confidence and experience 
of the study team, including the research coordinator 
and PI, in the later period is likely to have 
contrib-uted this apparent improvement.
Successful clinical trials involving burn patients 
are possible. Most of the evidence-based practices in 
burn care are from very successful single centers that 
have perfected the research enterprise with a defined 
patient population, standard treatment algorithms, 
and a consistent surgical team.10,11 Such centers 
have well-established basic science, animal, and 
transla-tional science labs12,13; perform 
randomized con-trolled trials to study treatment 
interventions14; and spearhead multicentered 
trials.15,16 These centers have established 
research protocols describing the risks, benefits, 
alternatives, and evidence and have the staff to 
provide information and resources for patients 
and families with questions or concerns. The 
experiences of these centers have educated them on 
the many pitfalls for which they are now prepared. 
We encourage these centers to describe their path to 
success and to advise young investigators how best 
to proceed in conducting clinical trials in burn.
In conclusion, modifications to our recruitment 
process appeared to successfully decrease time to 
enrollment of severely injured burn patients into 
noninterventional studies. Greater research coordi-
nator experience, flexible availability of study person-
nel for consent approach, and broad time windows 
for study inclusion are important to limit low accrual. 
Formal studies, including surveys of burn patient 
attitudes and beliefs, will be important to better 
understand barriers to recruitment and motivation 
for study enrollment in this unique population.
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